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Ionic Mechanisms that Underlie Ventricular Action Potential Prolonga-
tion following Loss of Caveolin-3 in Adult Transgenic Mice
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Ravi C. Balijepalli2, Timothy J. Kamp2, Natalia A. Trayanova1.
1Johns Hopkins University, Baltimore, MD, USA, 2University of Wisconsin,
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Caveolin proteins are involved in establishing membrane microstructure, lipid
raft organization, and cell signaling. In the heart, caveolin-3 (Cav3) predomi-
nates. Inherited or disease-induced Cav3 loss increases risk of sudden cardiac
death (SCD). We aimed to explore connections between Cav3 loss and arrhyth-
mogenic changes in the ventricular action potential (AP) by investigating the
Cav3 dependence of ionic currents. Drugs commonly used to disrupt or remove
Cav3 in cultured cells exclude any compensatory process likely to occur in
vivo. This motivated us to engineer a novel conditional Cav3 knockout
(Cav3-/-) mouse that survives to adulthood. We isolated ventricular cells for
electrophysiological experimentation.
AP duration (APD90) was prolonged from 2454 ms in WT to 9659 ms in
Cav3-/-, and several currents were affected. Reduced peak: L-type Ca2þ current
(ICaL), 21%; slow Kþ current, 81%; transient outward Kþ current, 57%; steady
state outward Kþ current (Iss), 43%. Late Naþ current was enhanced ~10-fold.
These changes were partially offsetting - preventing a simple account for the
APD90 increase. To relate changes in currents to changes in the AP, we devel-
oped a computational representation of Cav3-/- based on the Morotti et al.
mouse ventricular cell model and defined by fractional change in currents.
Unexpectedly, the relatively small change in relatively small Iss caused 33% of
total simulated AP prolongation. Though Iss conductance was reduced, peak Iss
actually increased in the dynamic setting of the simulated AP. Early in the AP,
lower Iss indirectly enhanced inward currents (importantly late ICaL) by extend-
ing the plateau phase, which in turn allowed Iss to more fully activate. This Iss/
ICaL process largely accounted for the pro-arrhythmic APD90 increase
followingCav3 loss and is therefore a candidate target for normalizing SCD risk.
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Diabetes Slows Heart Rate via Electrical Remodeling of KD Currents in
Sinoatrial Node Myocytes
Joshua R. St. Clair, Emily J. Sharpe, Andrew Hagar, Clayton Garthe,
Julie Juchno, Cathy Proenza.
Physiology & Biophysics, University of Colorado, Aurora, CO, USA.
Diabetes mellitus is associated with sinoatrial node dysfunction, as evidenced
by an increased risk of atrial fibrillation, pacemaker implantation due to brady-
cardia and cardiac death in diabetic patients. While sinoatrial node myocytes
(SAMs) generate the spontaneous action potentials (APs) that initiate each
heartbeat, little is known about how diabetes affects SAMs directly. In this
study, we used streptozoticin (STZ) -treated mice as a model of diabetic hyper-
glycemia. Four weeks after STZ injections, we found that both intrinsic heart
rate (measured during autonomic blockade) and maximum heart rate (measured
during restraint stress) were reduced in diabetic animals compared to pre-
treatment values. Current-clamp recordings from acutely isolated SAMs from
diabetic animals revealed corresponding reductions in spontaneous AP firing
rates. AP waveform analysis showed that the reduced firing rates in diabetic
cells resulted from a prolongation of the AP duration and a slowing of the
rate of repolarization. Accordingly, we observed significant decreases in steady
state and transient outward Kþ current densities in whole-cell voltage-clamp
recordings from SAMs from diabetic animals. Diabetes caused little or no
change in voltage-gated calcium currents in diabetic SAMs. The effects of dia-
betes on the AP waveform and firing rate were mimicked by application of
10 mM 4-aminopyridine in current clamp experiments and when the transient
outward Kþ current was reduced in a mathematical model of the sinoatrial
AP. These results suggest that diabetic sinoatrial node dysfunction results in
part from electrical remodeling of Kþ currents in sinoatrial node myocytes,
which paradoxically slows the spontaneous AP firing rate and thus heart rate.
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Madison, WI, USA.Cardiac L-type Ca2þ channels (LTCC) play essential role in multiple cellular
processes including excitation-contraction coupling, signaling and gene regula-
tion. Diverse families of regulatory and scaffolding proteins regulate the
LTCCs in the cardiomyocytes. Leucine-rich repeat containing 10 (LRRC10)
is a cardiac-specific scaffolding protein that plays a critical role in heart devel-
opment and function. Recently we have demonstrated that the Lrrc10-null
(Lrrc10-/-) mice develop dilated cardiomyopathy and Lrrc10-/- cardiomyocytes
exhibit reduced LTCC current (ICa,L). However, it is unclear how LRRC10 reg-
ulates LTCC function in the heart. To investigate the role of LRRC10 in the
regulation of LTCCs, we co-expressed the WT LRRC10 with LTCC channel
complex comprising of the Cav1.2, b2CN2, a2d subunits in HEK293 cells and
performed whole-cell patch clamp experiments. Co-expression of LRRC10
significantly enhanced (225%) the peak LTCC current (IBa,L 7557 pA/pF)
density compared to LTCC alone (3353 pA/pF).We then introduced a single
point mutation (substituted alanine for histidine) in the putative functional
interaction site at amino acid position 150 (H150A) of LRRC10. Co-
expression of LRRC10H150A caused significant reduction (27%) in IBa,L
(-5754 pA/pF) compared to WT LRRC10 co-expression. Furthermore,
G/Gmax analysis revealed a significant shift in the voltage dependence of acti-
vation to more negative potentials with the co-expression of either the WT
LRRC10 (V1/2,-21.7mV) or the H150A mutation (V1/2, 25.1mV) compared
to LTCC alone (V1/2,16.4mV). Finally, co-immunoprecipitation and western
blot analysis in HEK293 cells demonstrated that LRRC10 associates with
Cav1.2 subunit but not the Cav2 subunit. Moreover, co-expression of the
LRRC10 H150A mutation disrupted the association of Cav1.2 with LRRC10.
We conclude that LRRC10 may directly associate with Cav1.2 subunit and
regulate the LTCC function by enhancing the surface expression, density and
biophysical properties of the ICa,L.
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The Ca2D Clock is Not Governed by a Single CaMKII or PKA Phosphor-
ylation Site for Fight or Flight Responses
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Both CaMKII and PKA contribute to fight or flight heart rate (HR) increases in
response to isoproterenol or activity. CaMKII and PKA promote HR increases,
at least in part, by actions on ‘Ca2þ clock’ homeostatic proteins. The Ca2þ
clock mechanism for cardiac pacing relies on SR proteins governing SR
Ca2þ uptake and release. Inhibition of SR Ca2þ release by ryanodine slows
HR but we are unaware of any studies testing the potential for slowing SR
Ca2þ uptake to reduce HR. Phospholamban (PLN) is a negative regulator of
SERCA that acts to slow SR Ca2þ uptake. PLN phosphorylation is catalyzed
by PKA, at serine 16, or CaMKII, at threonine 17. PKA and CaMKII can
also promote SR Ca2þ release by catalyzing phosphorylation of the ryanodine
receptor (RyR2). CaMKII phosphorylation at Ser 2814 and PKA phosphoryla-
tion at Ser 2808 can increase RyR2 Ca2þ leak that drives cell membrane depo-
larizing inward current through the Naþ/Ca2þ exchanger. Despite the mounting
evidence that CaMKII and PKA sites on PLN and RyR2 are important for car-
diac pacing, the relative importance of these sites is unknown and the potential
for any particular site to exert a controlling influence over fight or flight phys-
iology is untested. Here we have taken advantage of genetically modified
mouse models where CaMKII and PKA sites are specifically ablated to inter-
rogate the role of each site and determine if any of these SR protein sites exer-
cises a decisive influence on HR responses to isoproterenol or activity. The
results from genetically modified mice harboring various PLN mutantions
(PLN-/-, N27A, S16A, T17A) and RYR2 mutations (S2808A and S2814A)
suggest that established CaMKII and PKA sites do not, by themselves, control
fight or flight HR responses.
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Background: We have previously shown that non-equilibrium reactivation of
the Na current (INa) drives Isoproterenol-induced phase-3 early afterdepolariza-
tions (EADs) in failing mouse ventricular myocytes. EAD initiation is
196a Monday, February 9, 2015secondary to potentiated sarcoplasmic reticulum Ca release and enhanced Na/
Ca exchange (NCX), and can be abolished by the INa blocker tetrodotoxin, but
not by the selective (in ventricles) late INa blocker ranolazine.
Aim. Since repolarization in human atrial myocytes is relatively rapid and
potently modulated by Ca (as in mouse ventricle), we investigate whether
the same EAD mechanism may occur in human atria. Indeed, phase-3 EADs
have been suggested to underlie re-initiation of atrial fibrillation (AF) after
termination upon autonomic stimuli - well recognized AF triggers.
Methods: We integrated a Markov model of INa (also describing the channel
interaction with ranolazine, similar to work by Clancy) in our human atrial
myocyte model. To recapitulate experimental results, we simulated rapid cell
pacing (10 Hz) in the presence of Acetylcholine (0.1 mM) and Isoproterenol
(1 mM), and assessed EAD occurrence upon return to sinus rhythm (1 Hz).
Results: Cellular Ca overload during fast pacing results in a transient period of
hyper-contractility after return to sinus rhythm. Here, fast repolarization and
enhanced NCX facilitate INa reactivation via the canonical gating mode (i.e.,
not late INa burst mode), which drives EAD initiation. Notably, in action poten-
tial clamp experiments, an EAD waveform elicits a lidocaine-sensitive inward
current during the EAD upstroke in pig atrial cells. Simulating ranolazine
administration reduces peak INa and leads to a faster repolarization, during
which INa fails to reactivate.
Conclusions: Our simulations suggest that non-equilibrium INa reactivation
critically contributes to arrhythmias in human atrial myocytes. Ranolazine
might be beneficial in this context by blocking peak (not late) atrial INa.
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Background: KCNQ1 (Q1, pore-forming channel subunit) and KCNE1 (E1,
regulatory subunit) associate to form the slow delayed rectifier (IKs) channel,
important for cardiac action potential repolarization. Although Q1/E1 are
obligatory partners in cardiomyocytes, in adult ventricular myocytes the two
are not well colocalized: E1 is on the lateral cell surface while Q1 is mainly
in the intracellular junctional SR. This appears to contradict data from heterol-
ogous expression or non-cardiac cell types, which suggest that Q1/E1 assemble
into IKs when they are still in ER or soon thereafter. The current study is de-
signed to distinguish between 2 scenarios. First, Q1 and E1 traffic from ER
to the plasma membrane together, followed by Q1 internalization to the ER/
SR compartment. Alternatively, Q1 and E1 traffic on different routes from
ER to their separate destinations.
Methods: COS-7 cells transfected with Q-GFP/E1-dsR are cultured in presence
of brefeldin A (BFA) for 12 – 16 hr, to allow protein translation without ER
exit. Cells are imaged in absence of BFA but presence of cycloheximi-
deþdynasore (blocking protein translation and endocytosis). Time-lapse
images (Zeiss 710, 37oC) of 4-um optic slice (to maximize capture of traf-
ficking events in thin cytosol of COS-7 cells) are recorded till the Q1-GFP
and E1-dsR distribution reaches quasi steady-state (> 2 hr).
Results: BFA removal allows ER exit and Golgi reconstruction. E1-dsR exits
ER in distinct vesicles, more frequently at the cell periphery. These vesicles
gradually cluster to the peri-nuclear region, entering the post-BFA Golgi.
Q1-QFP stays in the ER compartment for > 2 hr. Its ER location is confirmed
by FRAP experiments.
Conclusion: Our data support the second scenario. Experiments are in progress
to test whether E1-dsR and Q1-GFP behave the same when expressed in a car-
diac myocyte environment.
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In heart, HERG1A-HERG1B subunits generate the rapid component of de-
layed rectifier potassium current, IKr, critical for normal repolarization.
Congenital mutations in HERG1A lead to long QT syndrome-2 (LQTS-2),
a condition that increases susceptibility to fatal arrhythmias. Many LQTS-2
mutations that are localized to HERG1A C-terminus generate truncated vari-
ants and their behavior when co-expressed with HERG1B and their (patho)
physiological effects in heart are largely unknown. Therefore, we compared
the physiological impact and mechanistic bases of two HERG1A C-terminus
truncation mutations (G965X, R1014X). Bungarotoxin-binding optical assaysfor channel cell-surface expression and electrophysiological recordings were
carried out in Human Embryonic Kidney cells. R1014X displayed normal sur-
face density whereas, the G965X mutant, displayed a significant decrease in
channel surface density, which was fully rescued by wild-type HERG1A-
HERG1B subunits. Homo-multimeric (mutantþHERG1B), G965X and
R1014X channel subunits yielded currents with severely reduced current ampli-
tude. When co-expressed with wild-type HERG1A, both mutants exerted a
dominant negative effect but to different extents: G965X current amplitude
was partially rescued while R1014X current remained unchanged. Homo-
multimeric mutant channels displayed a significant rightward shift in the
activation curve which was partially (G965X), or not (R1014X) rescued with
wild-type HERG1A. The data reveal these mutants exert a purely biophysical
effect on hetero-multimeric (mutant HERG1A þ wild-type HERG1A þ
HERG1B) channels. These mechanistic insights may enhance therapies for
LQTS-2 mutations. Furthermore, we show for the first time that the R1014X
shows normal surface expression, but is non-functional and exerts a strong
dominant-negative effect on wild-type HERG1A channels which is in contrast
to existing data that demonstrates that R1014X causes HERG1A channel
dysfunction by defective trafficking. Finally, studies that explore the functional
impact of these mutations in heart will provide novel information that will be
more predictive of disease penetrance.
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The human ether-a-go-go related gene (hERG) encodes the voltage-gated
potassium channel responsible for conducting the rapid delayed rectifier potas-
sium current (IKr). Reduced IKr slows cardiac action potential repolarization
and is an underlying cause of cardiac arrhythmias associated with both in-
herited and acquired long QT syndrome (LQTS). Two subunits comprise the
hERG channel, hERG 1a and hERG 1b, both of which represent critical com-
ponents of cardiac repolarization. R25W is a hERG 1b mutation associated
with a case of intrauterine fetal death and previously shown to reduce hetero-
meric hERG 1a/1b current density in Chinese hamster ovarian cells1. The
mechanism of current reduction and a direct link to cardiac dysfunction has
not been described for R25W. We expressed R25W in HEK cells and human
induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) to define
the molecular, biophysical, and physiological consequences of R25W.
R25W significantly reduced 1a and 1b protein levels to 76.456.0% and
65.257.8% of control, respectively, in HEK cells coexpressing hERG 1a
and 1b. In iPSC-CMs, R25W transfection significantly reduced peak tail IKr
(0.850.1 pA/pF, n ¼ 10, p < 0.05) compared to either native IKr (1.750.2
pA/pF, n ¼ 5) or wild type 1b transfected iPSC-CMs (1.550.3 pA/pF,
n¼ 7). Interestingly, wild-type 1b did not affect peak tail IKr whereas transfec-
tion of either 1a alone (35.9 5 11.0 pA/pF, n ¼ 5) or 1a/1b together
(24.8511.2 pA/pF, n ¼ 5) dramatically increased current density. These
data identify R25W as a dominant negative mutation that reduces native IKr
and provide new evidence that hERG 1b fails to traffic as a homomeric channel
in human cardiomyocytes. Supported by NIH/R01HL081780 and the UW
Training Program in Translational Cardiovascular Science (T32HL007936).
1. Crotti et al., 2013, JAMA.Platform: Membrane Pumps, Transporters, and
Exchangers II
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Electrochemical gradients of sodium and protons are the primary driving forces
for a wide array of cellular processes mediated by membrane proteins, such as
energy conversion, solute uptake and multi-drug extrusion. The factors that
confer ion specificity to these systems are poorly understood. Sodium and
proton-driven systems of different functionality are often found in the same
organism, and membrane proteins within the same functional family frequently
feature distinct specificities despite a high similarity in their structures. There-
fore, it appears that the specificity of Hþ/Naþ-coupled systems is largely
